About us

Peter is a retired senior executive with over 30+ years of proven leadership across a diverse background in consumer-packaged goods, medical devices & diagnostics, nutritional supplements and OTC products with global experience in both large corporation and smaller PE and VC backed company environments.

Peter is an executive advisor for several private equity firms and serves as a director on boards.  Prior to his retirement, Peter was President and Chief Executive Officer of Atrium Innovations, a globally recognized leader in nutritional supplements with such brands as Garden of Life and Pure Encapsulations. Peter joined Atrium in mid-2014 after the company was taken private by Permira for $1.0 billion and led it through its successful acquisition by Nestlé in March 2018 for $2.3 billion, representing a strong 4.3x investment return. 

Before Atrium, Peter was with Johnson & Johnson for 25 years where he served as President of several of the company’s large divisions over his last 10+ years including J&J Consumer Healthcare, J&J Beauty Care, J&J OTC and LifeScan. During his tenure, Peter had the opportunity to run some of the world’s most iconic brands, including Neutrogena®, Aveeno®, Listerine®, Band-Aid®, Neosporin®, Tylenol®, Zyrtec®, OneTouch® and Splenda® among others.

Peter Luther has a BA in Economics from Kenyon College and an MBA from the Kellogg School at Northwestern University.